Literature DB >> 11234909

The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression.

H A Sackeim1, J G Keilp, A J Rush, M S George, L B Marangell, J S Dormer, T Burt, S H Lisanby, M Husain, C M Cullum, N Oliver, H Zboyan.   

Abstract

BACKGROUND: Chronic vagus nerve stimulation (VNS) is effective in the management of treatment-resistant epilepsy. Open-trial evidence suggests that VNS has clinically significant antidepressant effects in some individuals who experience treatment-resistant major depressive episodes. However, limited information regarding the effects of VNS on neurocognitive performance exists.
OBJECTIVE: The primary aim of this study was to determine whether VNS leads to neurocognitive deterioration.
METHOD: A neuropsychological battery was administered to 27 patients with treatment-resistant depression before and after 10 weeks of VNS. Thirteen neurocognitive tests sampled the domains of motor speed, psychomotor function, language, attention, memory, and executive function.
RESULTS: No evidence of deterioration in any neurocognitive measure was detected. Relative to baseline, improvement in motor speed (finger tapping), psychomotor function (digit-symbol test), language (verbal fluency), and executive functions (logical reasoning, working memory, response inhibition, or impulsiveness) was found. For some measures, improved neurocognitive performance correlated with the extent of reduction in depressive symptoms, but VNS output current was not related to changes in cognitive performance.
CONCLUSIONS: Vagus nerve stimulation in treatment-resistant depression may result in enhanced neurocognitive function, primarily among patients who show clinical improvement. Controlled investigation is needed to rule out the contribution of practice effects.

Entities:  

Mesh:

Year:  2001        PMID: 11234909

Source DB:  PubMed          Journal:  Neuropsychiatry Neuropsychol Behav Neurol        ISSN: 0894-878X


  29 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  The future of antidepressant pharmacotherapy.

Authors:  David Baldwin; Chris Thompson
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

Review 3.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

4.  Autistic spectrum disorder, epilepsy, and vagus nerve stimulation.

Authors:  Mariam Mettry Hull; Deepak Madhavan; Charles M Zaroff
Journal:  Childs Nerv Syst       Date:  2015-04-29       Impact factor: 1.475

Review 5.  Vagus nerve stimulation in psychiatry: a systematic review of the available evidence.

Authors:  Camelia-Lucia Cimpianu; Wolfgang Strube; Peter Falkai; Ulrich Palm; Alkomiet Hasan
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

6.  The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy.

Authors:  Leen De Taeye; Kristl Vonck; Marlies van Bochove; Paul Boon; Dirk Van Roost; Lies Mollet; Alfred Meurs; Veerle De Herdt; Evelien Carrette; Ine Dauwe; Stefanie Gadeyne; Pieter van Mierlo; Tom Verguts; Robrecht Raedt
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 7.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

Review 8.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 9.  Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).

Authors:  Mark S George; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.

Authors:  Alkomiet Hasan; Claus Wolff-Menzler; Sebastian Pfeiffer; Peter Falkai; Elif Weidinger; Andrea Jobst; Imke Hoell; Berend Malchow; Peyman Yeganeh-Doost; Wolfgang Strube; Silke Quast; Norbert Müller; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-26       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.